Approved Studies sorted on Review Date

ACTIVE STUDY: Resveratrol for the prevention of bone loss in postmenopausal women

Approval Status: Approved
Number: 121
Submission Date January 17, 2024
Is this study IRB-Approved? Yes
Date of NEXT IRB Review: [294]
Full Study Name: Resveratrol for the prevention of bone loss in postmenopausal women
Short Study Name: Resveratrol for the prevention of bone loss in postmenopausal women
College / Affiliation College of Health Sciences
Relevant Research Categories [328]
Location of Study: University of Delaware Main Campus, Newark, DE 19716, University of Delaware STAR Campus, 540 S College Ave, Newark, DE 19713
Description of Study:

The aim of this study is to determine the effects of resveratrol, a natural antioxidant found in various foods such as berries on bone health in postmenopausal women. Women will be randomly assigned to two groups: 1) the placebo group and 2) the resveratrol group. The resveratrol group will receive 500 mg resveratrol daily, and placebo group will receive placebo pills. Both groups will also receive 500 mg calcium plus 400 IU vitamin D daily.

Will participants be compensated for participation?
Inclusion and Exclusion Criteria:

If you are a woman 1-10 years postmenopausal, and have not been diagnosed with osteoporosis, you may be eligible to participate in our study!

“How to Apply” Description:

If you are interested, please call 302-831-7218 or email ChaiResearchLab@udel.edu

How to Apply Link:
How to Apply Email:
Contact Name: Bingqing
Contact Last Chai
Contact Email: ChaiResearchLab@udel.edu
Phone: 302-831-7218
PI Name: Sheau Ching
PI Last Chai
PI Email: scchai@udel.edu